Introduction: Heart failure with reduced ejection fraction (HFrEF) in Qatar has not been well characterized in the outpatient setting.
Objective: To describe the characteristics of patients with HFrEF who had improvement in their left ventricular ejection fraction (LVEF) and independent predictors of improvement.
Methods: This retrospective cohort study conducted at the advanced heart failure (HF) clinic in Qatar recruited patients who visited the clinic between January 2017 and December 2018. Adult patients were eligible if they were diagnosed with HFrEF (LVEF < 40%) and had two echocardiograms separated by at least 6 months.
Results: Of 582 eligible patients, 161 (27.7%) had improved LVEF. They were younger (53.4 vs. 57.3 years, = 0.002) and had shorter duration of HF diagnosis (4.3 vs. 5.6 years, = 0.001). They experienced lower rates of all-cause hospitalization (20.5% vs. 38.0%, = 0.001) and emergency department visits (25.5% vs. 35.9%, = 0.001), without a difference in hospital mortality rate, than those without LVEF improvement. Decreased odds ratio of improved LVEF was associated with per year increase in age (adjusted odds ratio [aOR]: 0.98, 95% confidence interval [CI]: 0.97-0.99, = 0.03), presence of left bundle branch block (aOR: 0.40, 95% CI: 0.20-0.80, = 0.001), duration of HF diagnosis (aOR: 0.85, 95% CI: 0.78-0.94, = 0.001), and ischemic HF etiology (aOR: 0.50, 95% CI: 0.30-0.77, = 0.001; compared with dilated etiology). Beta-blocker therapy was associated with higher odds of LVEF improvement (aOR: 2.65, 95% CI: 1.02-6.88, = 0.001).
Conclusion: Patients with HFrEF with improved LVEF were younger, had a nonischemic cardiomyopathy, and had significantly fewer hospitalizations and emergency department visits.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11867172 | PMC |
http://dx.doi.org/10.4103/heartviews.heartviews_34_24 | DOI Listing |
ESC Heart Fail
March 2025
Institute of Health Informatics Research, University College London, London, UK.
Aims: Atrial fibrillation (AF) is a frequent comorbidity in heart failure (HF). We analysed factors associated with new-onset atrial fibrillation in patients with heart failure using linked real-world UK data from primary and secondary care, along with findings from genome-wide association studies.
Methods And Results: Among 163 174 participants with a diagnosis of HF (January 1998 to May 2016) from Clinical Practice Research Datalink (CPRD) and Hospital Episodes Statistics (HES), 111 595 participants had no previous history of AF (mean age 76.
JACC Cardiovasc Interv
March 2025
Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University of Duisburg-Essen, Essen, Germany.
A global treatment algorithm was developed for the endovascular revascularization of femoropopliteal lesions and chronic total occlusions, aiming toward a more standardized approach to endovascular treatment in patients with peripheral artery disease. The following steps are proposed. 1) Evaluation of lesion morphology based on preprocedural imaging by Duplex sonography and intravenous ultrasound for selection of lesion preparation tools.
View Article and Find Full Text PDFChest
March 2025
University of Sousse, Faculty of Medicine of Sousse, Farhat HACHED Hospital, Heart Failure (LR12SP09) Research Laboratory, Sousse, Tunisia. Electronic address:
J Am Coll Cardiol
March 2025
University of Mississippi, Jackson, Mississippi, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!